Evidence map›Paper›PMID 27980599›Full record

ArticleNutrition & metabolism2016

Effects of controlled doses of Oxyelite Pro on physical performance in rats.

Paulo Vinicios Camuzi Zovico, Victor Magalhães Curty, Marcos André Soares Leal, Eduardo Frizzera Meira, Daniel Ventura Dias, Lívia Carla de Melo Rodrigues, Silvana Dos Santos Meyrelles, Edilamar Menezes De Oliveira, Paula Frizera Vassallo, Valério Garrone Barauna

Open access · goldAbstract read
In one paragraph

Article in Nutrition & metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Paulo Vinicios Camuzi ZovicoDepartment of Physiological Sciences, University of Espírito Santo, Av. Marechal Campos, 1468 - Maruípe, Vitória, 29043-900 Brazil.
Victor Magalhães CurtyDepartment of Physiological Sciences, University of Espírito Santo, Av. Marechal Campos, 1468 - Maruípe, Vitória, 29043-900 Brazil.
Marcos André Soares LealDepartment of Physiological Sciences, University of Espírito Santo, Av. Marechal Campos, 1468 - Maruípe, Vitória, 29043-900 Brazil.
Eduardo Frizzera MeiraDepartment of Physiological Sciences, University of Espírito Santo, Av. Marechal Campos, 1468 - Maruípe, Vitória, 29043-900 Brazil.
Daniel Ventura DiasUNIPAMPA, Federal University of Pampa, Uruguaiana, Brazil.
Lívia Carla de Melo RodriguesDepartment of Physiological Sciences, University of Espírito Santo, Av. Marechal Campos, 1468 - Maruípe, Vitória, 29043-900 Brazil.
Silvana Dos Santos MeyrellesDepartment of Physiological Sciences, University of Espírito Santo, Av. Marechal Campos, 1468 - Maruípe, Vitória, 29043-900 Brazil.
Edilamar Menezes De OliveiraSchool of Physical Education and Sport, University of Sao Paulo, Sao Paulo, Brazil.
Paula Frizera VassalloDepartment of Physiological Sciences, University of Espírito Santo, Av. Marechal Campos, 1468 - Maruípe, Vitória, 29043-900 Brazil.
Valério Garrone BaraunaDepartment of Physiological Sciences, University of Espírito Santo, Av. Marechal Campos, 1468 - Maruípe, Vitória, 29043-900 Brazil.
Universidade Federal do Espírito Santo · BRUniversidade de São Paulo · BRUniversidade Federal do Pampa · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOxyElite Pro (OEP) is a dietary supplement to increase metabolism which contains as key stimulant the ingredient 1,3-dimethylamylamine (DMAA). Serious adverse effects have been reported after OEP consumption however, these effects are related to poisoning or overdose. To our knowledge, no one studied the effects of OEP at controlled doses. Thus, the aim of this study was to evaluate acute and chronic OEP affects, at controlled doses in Wistar rats, on physical performance, metabolic parameters, liver injury markers and oxidative stress markers and mitochondrial biogenesis in skeletal muscle.

methodsRats were divided in control, 4.3 mg OEP/kg, 12.9 mg OEP/kg and 25.8 mg OEP/kg. All groups were submitted to supplementation with OEP for 4 weeks and the experimental protocols were performed 30 min after the first OEP administration (acute response) and 30 min after the last OEP administration at the end of the forth week (chronic response).

resultsRunning distance and running time increased after acute administration of 12.9 mg OEP/kg (2.6-fold) and 25.8 mg OEP/kg (2.8-fold). Since no effect on the exercise tolerance test was observed at the lower OEP dose (4.3 mg OEP/kg), this group was removed from further analyzes. On other hand, running distance and running time decreased after daily supplementation for 4 weeks also in both groups (64% in 12.9 mg OEP/kg and 72% in 25.8 mg OEP/kg). Chronic supplementation at both 12.9 and 25.8 mg OEP/kg decreased TBARS levels in soleus muscle (36 and 31%) and liver (43 and 25%). AOPP was also decreased by both doses in the liver (39 and 45%). Chronic administration of the highest dose, 25.8 mg OEP/kg, was able to reduce mRNA expression of PGC-1α in soleus muscle (25%). No effect was found in other analyses such as spontaneous physical activity, body weight, food and water intake, hepatic toxicity, cardiac oxidative stress and mitochondrial DNA amount.

conclusionMaximum and not recommended doses of OEP ingested acutely presented stimulating effect on the ability to exercise. However, its daily consumption for 4 weeks showed antioxidant effects in soleus muscle and liver which may have decreased the PGC-1α mRNA expression on soleus muscle and contributed to the impaired performance in the exercise tolerance test.

Indexed as

Dietary supplementsLiverMitochondrial biogenesisOxidative stressPerformance

Identifiers

PMID27980599
PMCPMC5139112
OpenAlexW2560677306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.